Partner change, birth interval and risk of pre-eclampsia: A paradoxical triangle

Paediatric and Perinatal Epidemiology

Volumn 21, Issue SUPPL. 1, 2007, Pages 31-35

  Zhang, Jun ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Change in partner; Paternity; Pre eclampsia; Pregnancy interval; Statistical artefact

Indexed keywords

CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY PLANNING; FEMALE; HUMAN; PREECLAMPSIA; PROCESS MODEL; RISK ASSESSMENT; RISK REDUCTION; SEXUALITY; STATISTICAL ANALYSIS;

EID: 34250182864     PISSN: 02695022     EISSN: 13653016     Source Type: Journal    
DOI: 10.1111/j.1365-3016.2007.00835.x     Document Type: Conference Paper

References (28)

1. Zhang J, Zeisler J, Hatch MC, Berkowitz G. Epidemiology of pregnancy-induced hypertension. Epidemiologic Reviews 1997 19: 218 232.
2. Zhang J, Troendle JF, Levine RJ. Risks of hypertensive disorders in the second pregnancy. Paediatric and Perinatal Epidemiology 2001 15: 226 231.
3. Dekker G. The partner's role in the etiology of preeclampsia. Journal of Reproductive Immunology 2002 57: 203 215.
4. Marti JJ, Herrmann U. Immunogestosis: a new etiologic concept of 'essential' EPH gestosis, with special consideration of the primigravid patient. American Journal of Obstetrics and Gynecology 1977 128: 489 493.
5. Klonoff-Cohen HS, Savitz DA, Cefalo RC, McCann MF. An epidemiologic study of contraception and preeclampsia. JAMA 1989 262: 3143 3147.
6. Mills JL, Klebanoff MA, Graubard BL, Carey JC, Berendes HW. Barrier contraceptive methods and preeclampsia. JAMA 1991 265: 70 73.
7. Koelman CA, Coumans ABC, Nijman HW, Doxiadis IIN, Dekker GA, Claas FHJ. Correlation between oral sex and a low incidence of preeclampsia: a role for soluble HLA in seminal fluid? Journal of Reproductive Immunology 2000 46: 155 166.
8. Wimalasundera RC, Larbalestier N, Smith JH, de Ruiter A, McG Thom SA, Hughes AD, et al. Preeclampsia, antiretroviral therapy, and immune reconstitution. Lancet 2002 360: 1152 1154.
9. Mattar R, Amed AM, Lindsey PC, Sass N, Daher S. Preeclampsia and HIV infection. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2004 117: 240 241.
10. Frank KA, Buchmann EJ, Schackis RC. Does human immunodeficiency virus infection protect against preeclampsia-eclampsia? Obstetrics and Gynecology 2004 104: 238 242.
11. European Collaborative Study. Pregnancy-related changes in the longer-term management of HIV-infected women in Europe. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2003 111: 3 8.
12. Suy A, Martinez E, Coll O, Lonka M, Palacio M, de Lazzari E, et al. Increased risk of preeclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS 2006 20: 59 66.
13. Zhang J, Patel G. Partner change and perinatal outcomes: a systematic review. Paediatric and Perinatal Epidemiology 2007 21 (Suppl.1 47 58.
14. Trogstad LIS, Esklid A, Magnus P, Samuelsen SO, Nesheim BI. Changing paternity and time since last pregnancy; the impact on pre-eclampsia risk. A study of 547,238 women with and without previous pre-eclampsia. International Journal of Epidemiology 2001 30: 1317 1322.
15. Skjaerven R, Wilcox AJ, Lie RT. The interval between pregnancies and the risk of preeclampsia. New England Journal of Medicine 2002 346: 33 38.
16. Basso O, Christensen K, Olsen J. Higher risk of pre-eclampsia after change of partner. An effect of longer interpregnancy intervals? Epidemiology 2001 12: 624 629.
17. Dekker G, Robillard PY. The birth interval hypothesis - does it really indicate the end of the primipaternity hypothesis? Journal of Reproductive Immunology 2003 59: 245 251.
18. Basso O, Weinberg CR, Baird DD, Wilcox AJ, Olsen J. Subfecundity as a correlate of preeclampsia: a study within the Danish National Birth Cohort. American Journal of Epidemiology 2003 157: 195 202.
19. Gezer S. Antiphospholipid syndrome. Disease-a-Month 2003 49: 691 742.
20. Thomson F, Shanbhag S, Templeton A, Bhattacharya S. Obstetric outcome in women with subfertility. British Journal of Obstetrics and Gynaecology 2005 112: 6 32 637.
21. Greenland S. Quantifying biases in causal models: classical confounding vs collider-stratification bias. Epidemiology 2003 14: 300 306.
22. Hernan MA, Hernandez-Diaz S, Werler MM, Mitchell AA. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. American Journal of Epidemiology 2002 155: 176 184.
23. Li DK, Wi S. Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy. American Journal of Epidemiology 2000 151: 57 62.
24. Mostello D, Catlin TK, Roman L, Holcomb WL, Leet T. Preeclampsia in the parous woman: who is at risk? American Journal of Obstetrics and Gynecology 2002 187: 425 429.
25. Roberts JM, Gammill H. Preeclampsia and cardiovascular disease in later life. Lancet 2005 366: 961 962.
26. Sibai BM, El-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. American Journal of Obstetrics and Gynecology 1986 155: 1011 1016.
27. Esplin MS, Fausett MB, Fraser A, Kerber R, Mineau G, Carrillo J, et al. Paternal and maternal components of the predisposition to preeclampsia. New England Journal of Medicine 2001 344: 867 872.
28. Skjaerven R, Vatten LJ, Wilcox AJ, Ronning T, Irgens LM, Lie RT. Recurrence of preeclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. British Medical Journal 2005 331: 877 881.